new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Dr Reddy s Laboratories Ltd patents

Recent patent applications related to Dr Reddy s Laboratories Ltd. Dr Reddy s Laboratories Ltd is listed as an Agent/Assignee. Note: Dr Reddy s Laboratories Ltd may have other listings under different names/spellings. We're not affiliated with Dr Reddy s Laboratories Ltd, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Dr Reddy s Laboratories Ltd-related inventors




Date Dr Reddy s Laboratories Ltd patents (updated weekly) - BOOKMARK this page
03/16/17Pharmaceutical compositions of cetp inhibitors
03/16/17Modified release doxycycline composition
03/02/17Phospholipid depot
02/09/17Pharmaceutical composition for treating migraine
01/19/17Topical retinoid compositions
01/05/17Substituted heterocyclic acetamides as kappa opioid receptor (kor) agonists
12/29/16Process for purification and isolation of estrogens
12/15/16Topical formulations comprising a steroid
12/08/16Parental compositions of celecoxib
12/01/16Oral composition of celecoxib for treatment of pain
10/13/16Pharmaceutical compositions for minocycline
09/29/16Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (trka) inhibitors
09/15/16Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (trk) inhibitors
08/18/16Topical formulations comprising a steroid
08/18/16Topical formulations comprising a steroid
07/07/16Preparation of lenalidomide
05/19/16Modified release doxycycline composition
02/18/16Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (cetp) inhibitors
02/11/16Parenteral diclofenac composition
01/07/16Pharmaceutical compositions of cetp inhibitors
12/31/15Selectable single dose auto-injector and methods of making and using same
12/24/15Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (trka) inhibitors
10/29/15Phospholipid depot
09/17/15Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (trk) inhibitors
08/13/15Amorphous mirabegron and processes for crystal forms of mirabegron
08/13/15Parenteral compositions of celecoxib
08/06/15Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
06/18/15Substituted heterocyclic compounds as tropomyosin receptor kinase a (trka) inhibitors
05/21/15Preparation of febuxostat
02/19/15Selectable single dose auto-injector and methods of making and using same
01/29/15Substituted heterocyclic acetamides as kappa opioid receptor (kor) agonists
01/01/15Substituted heterocyclic compounds as tropomyosin receptor kinase a (trka) inhibitors
12/18/14Process for purification and isolation of estrogens
12/18/14Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (trk) inhibitors
09/25/145 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester-transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis
09/11/14Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (cetp) inhibitors
08/28/14Process for preparation of pregabalin
08/21/14Preparation of fingolimod and its salts
07/03/14Lorcaserin hydrochloride
06/05/14Azacitidine process and polymorphs
05/22/14Bendamustine formulations
05/15/14Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
03/06/14Solid forms of pemetrexed
02/20/14Febuxostat pharmaceutical compositions
11/14/13Kappa opioid receptor agonists
10/24/13Preparation of polypeptides and salts thereof
10/17/13Preparation of prasugrel hydrochloride
10/03/13Oral metronidazole pharmaceutical compositions
09/19/13Novel forms of apixaban
09/12/13Stable pharmaceutical compositions of fesoterodine
08/29/13Preparation of crystalline bazedoxifene and its salts
08/15/13Glatiramer acetate molecular weight markers
08/15/13Enhanced protein expression
08/15/13Asenapine maleate
08/08/13Process for the preparation of imatinib mesylate
07/04/13Process for the preparation of a single enantiomer of 3-aminopiperidine dihydrochloride
07/04/13Lenalidomide solvates and processes
06/27/13Processes for preparing pemetrexed
06/27/13Preparation of febuxostat
06/20/13Preparation of bendamustine and its salts
05/09/13Purification of proteins
03/07/13Sustained release donepezil formulations
08/23/12Topical formulations comprising a steroid
05/31/12Enzymes and methods for resolving amino vinyl cyclopropane carboxylic acid derivatives
05/24/12Preparation of fipamezole
Patent Packs
04/26/12Production of trans-4-aminocyclopent-2-ene-1-carboxylic acid derivatives
03/15/12Modified release niacin pharmaceutical formulations
02/23/12Fixed dose drug combination formulations
02/23/12Preparation of decitabine
02/16/12Sulfonamide compounds for the treatment of respiratory disorders
11/10/11Preparation of docetaxel
07/08/10Crystalline polymorphic forms of fexofenadine
06/10/10Novel heterocyclic compounds as gata modulators
06/10/10Novel biccyclic compounds as gata modulators
03/11/105(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the treatment of cancer







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Dr Reddy s Laboratories Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dr Reddy s Laboratories Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';